Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
-1.99%
+0.14%
-3.06%
ORGO
Organogenesis Holdin
$4.23
Login to see Organogenesis Holdin (ORGO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Risk Analysis
Earnings are forecast to decrease
Chart
$4.77 (-11.32%)
$4.3 (-1.63%)
$3.15 (+34.29%)
$3.07 (+37.79%)
ORGO has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
ORGO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
ORGO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ORGO Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayORGO Earnings
The TTM reflects 12-month period, providing review of ORGO financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is ORGO current stock price?
What are ORGO stock strengths?
What risks are associated with ORGO stock?
When is ORGO next earnings report?
What is ORGO market cap and volume?
What is ORGO's current Stock IQ?
Should I buy ORGO stock right now?
Is ORGO a Strong Buy right now?
What does a 'Strong Buy' rating mean for ORGO?
What does a 'Strong Sell' rating mean for ORGO?
What factors influence ORGO's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.32%
-1.99%
+0.14%
-3.06%
ORGO
Organogenesis Holdin
Current Price
$4.23
Stock Insights
Risk Analysis
Earnings are forecast to decrease
Login to unlock Organogenesis Holdin (ORGO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$4.77 (-11.32%)
$4.3 (-1.63%)
$3.15 (+34.29%)
$3.07 (+37.79%)
ORGO Analysts Opinion
ORGO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
ORGO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ORGO Street view is unimpressive and have negative views on the near-term outlook
ORGO has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
Average key support and resistance price levels.
Login to displayORGO Earnings
The TTM data reflects the most recent 12-month period, providing overview of ORGO financial performance.
ORGO Financial Health
The company financial health has moderately improved over the past year
Financial Score
ORGO Latest Analysis
Organogenesis: Mixed ReNu Data But Policy Tailwinds And Growth Remain ish.
Mon Sep 29, 2025
Why Is Organogenesis Stock Trading Lower Friday?. ) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu a cryopreserved amniotic suspension allograft (ASA) for the management of symptoms associated with .ReNu is a cryopreserved amniotic suspension allograft (ASA) developed for managing symptomatic knee osteoarthritis.ReNu consists of amniotic fluid cells and micronized amniotic membrane and contains cellular growth factor and extracellular matrix com
Fri Sep 26, 2025
Organogenesis knee osteoarthritis therapy misses primary endpoint in trial.
Thu Sep 25, 2025
Organogenesis stock falls after knee osteoarthritis trial misses endpoint.
Thu Sep 25, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ORGO Stock trends
ORGO Stock performance
ORGO Stock analysis
ORGO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings